SynthesisPloS one2014

Systematic review of the risk of adverse outcomes associated with vascular endothelial growth factor inhibitors for the treatment of cancer.

Labib Imran Faruque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.